Search | Clinical Trials Finder

Conditions: Nasogastric Tube
Interventions: Gravitas FT and Gravitas FT Monitor guidance; Device
Lead sponsor: Gravitas Medical, Inc.; Industry
Eligibility: 0 Weeks to 2 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 5
States / cities: Stanford, California • Savannah, Georgia • Boston, Massachusetts + 2 more

Conditions: Pediatric Cancer, Nutrition Related Cancer, Nutrition Aspect of Cancer, Muscle Loss, Malnutrition, Child
Interventions: Oral Nutrition Supplement, Tube Feed, Cyproheptadine, Olanzapine, Standard of Care; Dietary Supplement · Drug · Other
Lead sponsor: Corey Hawes; Other
Eligibility: 2 Years to 19 Years
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Central Venous Catheters
Interventions: Ben-Guard Garment; Device
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 0 Years to 10 Years
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Infant Development, Stress
Interventions: Multisensory Early Oral Administration of Human Milk (M-MILK); Other
Lead sponsor: Loyola University; Other
Eligibility: 0 Years to 1 Year
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Maywood, Illinois

Conditions: ICU Delirium, Critical Illness
Interventions: Ketone monoester, Placebo; Drug
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Infection
Interventions: Feeding tube dwell time of 48 hours, Feeding tube dwell time of 7 day; Device
Lead sponsor: University of Florida; Other
Eligibility: 30 Weeks to 40 Weeks
Enrollment: 151 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2023
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Hepatitis C, Hepatitis C Virus Infection, Response to Therapy of
Interventions: glecaprevir/pibrentasvir (GLE/PIB); Drug
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: San Diego, California

Conditions: Critical Illness, Malnutrition, Gastrostomy, Procedural Sequelae, Trauma, Surgery, Mechanical Ventilation
Interventions: noFast: Start tube feeds within 1 hour of procedure; Dietary Supplement
Lead sponsor: Carilion Clinic; Other
Eligibility: 18 Years to 100 Years
Enrollment: 1,200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2026
U.S. locations: 1
States / cities: Roanoke, Virginia

Conditions: Feeding Patterns, Sleep, Glucose Intolerance
Interventions: Time-of-day of enteral nutrition provision (daytime first), Time-of-day of enteral nutrition provision (nighttime first); Dietary Supplement
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Essential Fatty Acid Deficiency (EFAD)
Interventions: Clinolipid, Intralipid; Drug
Lead sponsor: Baxter Healthcare Corporation; Industry
Eligibility: 0 Years to 17 Years
Enrollment: 101 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 9
States / cities: Mobile, Alabama • New Haven, Connecticut • Orlando, Florida + 6 more

Conditions: Solid Tumor, Central Nervous System Tumor, Lymphoma, Leukemia
Interventions: Neratinib; Drug
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 3 Years to 21 Years
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2026
U.S. locations: 8
States / cities: Phoenix, Arizona • Little Rock, Arkansas • Palo Alto, California + 5 more

Conditions: Critical Illness, Surgery, Aspiration Pneumonia
Interventions: Gastric Ultrasound; Diagnostic Test
Lead sponsor: Dartmouth-Hitchcock Medical Center; Other
Eligibility: 18 Years to 100 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Lebanon, New Hampshire

Conditions: Enteral Nutrition
Interventions: electromagnetic placement device; Device
Lead sponsor: Parkview Health; Other
Eligibility: 18 Years and older
Enrollment: 119 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024
U.S. locations: 1
States / cities: Fort Wayne, Indiana

Conditions: Critical Illness, Sleep Deprivation, Circadian Rhythm Sleep Disorder, Unspecified
Interventions: Chronobundle - light, chronobundle - feeding, chronobundle - mobility, chronobundle - sleep; Other
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Enrollment: 160 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2029
U.S. locations: 2
States / cities: New Haven, Connecticut

Conditions: Children Requiring Amino Acid-based Formula Tube Feeding, Enteral Feeding Intolerance
Interventions: Enteral Formula; Other
Lead sponsor: Société des Produits Nestlé (SPN); Industry
Eligibility: 1 Year to 18 Years
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Protein Feeding in Post-traumatic Injury Patients
Interventions: Routine Nutritional Support plus supplemental IV amino acids, Routine Nutritional Support; Drug · Other
Lead sponsor: Boston Medical Center; Other
Eligibility: 18 Years to 65 Years
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Enteral Nutrition
Interventions: Nutriplace™ System; Device
Lead sponsor: Nutriseal L.P; Industry
Eligibility: 21 Years and older
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Feeding Tube, Children With Medical Complexity, Tracheostomy, Feeding Disorder, Infancy or Early Childhood
Interventions: Tube weaning therapy intervention, Feeding Group; Other
Lead sponsor: University of Chicago; Other
Eligibility: Up to 3 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Enteral Feeding, Nutrition Disorders
Interventions: Intermittent feed participant, Continuous feeds participant; Dietary Supplement
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Crohn Disease
Interventions: Nutritional therapy; Other
Lead sponsor: Dale Lee; Other
Eligibility: 8 Years to 21 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Transpulmonary Pressure, Pressure.Rate Product, Guide to Mechanical Ventilator Management, Extubation Readiness
Interventions: Transpulmonary Pressure measurement; Device
Lead sponsor: Children's Hospital Los Angeles; Other
Eligibility: 1 Week to 18 Years
Enrollment: 55 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2024
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Congenital Heart Defects, Growth Failure
Interventions: Arm 1: NPO by mouth pre-operative, Arm 2: Fresh Breast Milk pre-operative; Other
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 37 Weeks to 40 Weeks
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: no Primary Disease; ICU Patient Who Require Enteral Nutrition
Interventions: Tiger Tube; Device
Lead sponsor: Thomas Jefferson University; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2007
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Autosomal Recessive Polycystic Kidney (ARPKD)
Interventions: Tolvaptan Suspension, Tolvaptan Tablets; Drug
Lead sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.; Industry
Eligibility: 28 Days to 18 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 12
States / cities: Washington D.C., District of Columbia • Atlanta, Georgia • Chicago, Illinois + 9 more

Search by objective public record fields.

Gravitas Feeding Tube System Placement Validation in Neonates

Pediatric Oncology Nutrition Intervention Trial

Efficacy of Ben-Guard Garment in Reducing Pediatric Central Line Complications

Multisensory Early Oral Administration of Human Milk in Preterm Infants

Exogenous Ketone Supplementation in ICU Delirium

Optimal Feeding Tube Dwell Time in VLBW Infants to Reduce Feeding Tube Contamination

Prevention of Transmission of Hepatitis C Virus (HCV) From HCV-Viremic Organ Donor

RCT: Early Feeding After PEG Placement

The Impact of Overnight Nutrition Support on Sleep and Circadian Rhythm Disruption in the ICU

Pediatric Study to Evaluate Risk of Developing Essential Fatty Acid Deficiency When Receiving Clinolipid or Standard-of-Care Lipid Emulsion (Part A)

Safety and Dose Finding Study of Neratinib in Children and Young Adults With Cancer That Has Returned or Not Responded to Treatment

Gastric US in ICU Patient

DrIFT 2 Study: Displacement in Feeding Tubes

Reestablishing Sleep and Circadian Alignment in Medical Intensive Care Unit (MICU) Patients Via a Mechanistic RCT of an Sleep Chronobundle

Retrospective Review of Amino Acid Formula Use at a Children's Center

Early and Adequate Protein Feeding Post-Traumatic Injury

Feasibility Study to Evaluate Safety of Nutriseal™ Nutriplace™ System

Let's E.A.T.! (Eating With Assistive Technology): An Intervention to Support Children With Feeding Tubes and Tracheostomies

Intermittent Versus Continuous Enteral Nutrition in Mechanically Ventilated Patients in the Medical Intensive Care Unit

Reverse Engineering of Exclusive Enteral Nutrition

Measuring Lung Pressures in Critically Ill Children Who Are on Mechanical Ventilation

Intestinal Function in Neonates With Complex Congenital Heart Disease

A Research Study to Test (2) Two Different Types of Feeding Tubes Used in the Intensive Care Unit

A Study to See if Tolvaptan is Safe in Infants and Children Who at Enrollment Are 28 Days to Less Than 18 Years Old With Autosomal Recessive Polycystic Kidney Disease (ARPKD)